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defined bacterial mutants. Until recently, this type of
analysis has not been possible with M. tuberculosis,
mostly because of our inability to genetically manipulate
this organism and the consequent lack of defined mu-
tants with specific phenotypes. These barriers have
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†Howard Hughes Medical Institute been surmounted such that multidisciplinary investiga-
tion into M. tuberculosis pathogenesis is now possible,Department of Microbiology and Immunology
Albert Einstein College of Medicine an enterprise that has accelerated dramatically due to
the completion of the genome sequence of M. tuberculo-1300 Morris Park Ave.
Bronx, New York 10461 sis (Cole et al., 1998). This review will outline present
efforts to understand the pathogenesis of this unique
bacterial infection, focusing primarily on insights gained
from recently isolated M. tuberculosis mutants with al-
“If we ask further what significance belongs to the results
tered growth kinetics in experimental animals. This re-
gained in this study of tuberculosis it must be considered
view is not intended to comprehensively detail the in-
a gain for science that it has been possible for the first
credible breadth of the mycobacterial literature, but
time to establish the complete proof of the parasitic
rather to highlight and interpret recent advances and to
nature of a human infectious disease, and this of the
point to future directions.
most important one. So far such proof was established
only for anthrax, while in a number of other infectious
The Ongoing M. tuberculosis Epidemicdiseases in human beings, for example relapsing fever,
The global burden of M. tuberculosis infection is over-wound infections, leprosy, gonorrhoea, it was only
whelming. In addition, Bovine Tuberculosis (caused byknown that parasites occur simultaneously with the
Mycobacterium bovis) and Leprosy (caused by Myco-pathogenic process, but the causal connection between
bacterium leprae) remain significant global health prob-the two has not been established. It may be expected
lems. Recent estimates of Tuberculosis disease burdenthat the elucidation of the aetiology of tuberculosis will
documented approximately 1.86 billion people infectedprovide new viewpoints for the study of other infectious
with M. tuberculosis with 16.2 million cases of activediseases.”
disease. These active cases resulted in approximately—Robert Koch, 1882
2 million deaths in 1997, an average global case fatality
rate of 23% (Dye et al., 1999). These impressive statistics
Tuberculosis (TB) is a bacterial infectious disease are even more daunting when compared to the relative
caused by the obligate human pathogen, Mycobacte- rarity of lethal TB in the industrialized world due to effec-
rium tuberculosis. Mycobacteria are a distinctive rod- tive antibiotic therapy. Fully drug-sensitive M. tuberculo-
shaped bacteria that share a common property of a sis infection in an immunocompetent patient must be
lipid-rich cell wall that avidly retains Carbol fuchsin dye treated for at least 6 months with multiple antibiotics to
even in the presence of acidic alcohol (acid fast stain- achieve reliable clinical cure rates (Council, 1974; Cohn
ing). Despite longstanding intense efforts to control this et al., 1990). The financial and logistical barriers to ad-
disease, Tuberculosis remains an expanding global ministering these drug regimens in the areas where TB
health crisis that mandates new therapeutic and preven- is most prevalent are enormous. Furthermore, microbial
tative strategies. Although a wealth of information has resistance to commonly used antituberculous drugs is
been gathered about M. tuberculosis over many de- increasingly common, both in primary isolates and as a
cades of research into the bacteriology, cell biology, result of failed treatment (Surveillance, 1997). Therefore,
biochemistry, and immunology of this infection (Barks- development of new drugs active against M. tuberculo-
dale and Kim, 1977; Ratledge and Stanford, 1982; Kub- sis, particularly drugs that would allow shorter courses
ica and Wayne, 1984; Bloom, 1994; McKinney et al., of therapy, is a major priority of M. tuberculosis investi-
1998; Hatfull and Jacobs, 2000), investigation of this gation. In addition, BCG, the widely administered live
bacterial pathogen has lacked the multidisciplinary ap- attenuated vaccine against TB, is inconsistently effec-
proach that has evolved from the investigation of geneti- tive in adults (reviewed in McKinney et al., 1998). There-
cally tractable and fast growing bacterial pathogens fore, understanding the pathogenic strategies of M. tu-
such as Salmonella, Yersinia, Shigella, and Listeria. berculosis on a molecular level will allow both the
These organisms, among others, have given rise to the development of new drugs and the design of either live
integrated discipline of microbial pathogenesis (Finlay attenuated or subunit vaccine candidates to combat this
and Falkow, 1997), also known as cellular microbiology global health emergency.
(Cossart et al., 1996). This discipline probes the molecu-
lar interactions between specific microbial products and Natural History of M. tuberculosis Infection
the host cell, predominantly through the examination of in Humans
In order to understand the pathogenesis of M. tuberculo-
sis infection on a molecular level, it is essential to under-‡ To whom correspondence should be addressed (e-mail: jacobsw@
hhmi.org). stand the clinical behavior of this pathogen in its only
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natural host. Because M. tuberculosis has no known nate regulation of multiple genes. Although we know
reservoir outside of man, the environments to which the relatively little about the molecular events that mediate
organism must respond are defined solely by its natural these three pathogenic stages, the recent successful
history within its host. Tuberculosis is a disease that is isolation of defined mutants, and their careful character-
almost exclusively transmitted by aerosolized droplets izations, suggests that M. tuberculosis employs novel
containing infectious M. tuberculosis. These droplets strategies to achieve both replication and persistence.
are generated by the cough of a person with M. tubercu-
losis lung infection and are inhaled by an uninfected M. tuberculosis and the Macrophage
person. The inhaled bacilli lodge in the terminal air M. tuberculosis primarily infects macrophages. In con-
spaces of the lung where they enter and replicate within trast to other bacterial pathogens that avoid phagocyto-
alveolar macrophages. The initial, or primary, infection sis as a specific pathogenic strategy, M. tuberculosis is
with M. tuberculosis involves replication of the organism promiscuous in its use of multiple cell surface receptors
at the initial pulmonary site of infection, spread to local to gain entry into macrophages (Ernst, 1998; reviewed
lymph nodes within the lung, and eventual dissemination in Aderem and Underhill, 1999). These receptors include
of infection to remote sites in the body. Despite this the mannose receptor, complement receptors, and Fc
successful initial parasitization of the human host, the receptors. Once inside the host macrophage, M. tuber-
primary infection is almost invariably asymptomatic in culosis resides within a membrane-bound vacuole. It is
adults. With the onset of the host immune response, clear that M. tuberculosis modifies the maturation of
active bacterial replication and dissemination are con- this phagosomal compartment in order to enhance its
trolled. Although the human immune response against own intracellular survival (Armstrong and Hart, 1971;
M. tuberculosis is highly effective in controlling the pri- Clemens and Horwitz, 1995). This altered phagosomal
mary infection, the organism is almost never eradicated. maturation is associated with alterations in the protein
Thus, M. tuberculosis is foremost among bacterial patho- content of the vacuole including altered Rab GTPase
gens in its ability to establish and maintain latency, a composition (Via et al., 1997; Clemens et al., 2000), ex-
period during which the infected person does not have clusion of the vacuolar proton ATPase with consequent
clinically apparent Tuberculosis, but harbors M. tuber- lack of acidification (Sturgill-Koszycki et al., 1994), and
culosis organisms able to reactivate at a later date. The retention of a protein designated TACO (Ferrari et al.,
only clinical evidence of M. tuberculosis infection during 1999). Uptake of mycobacteria by macrophages and
latency is delayed type hypersensitivity against myco- subsequent retention of TACO on the phagosome ap-
bacterial antigens, demonstrated by a tuberculin skin pears to be dependent upon the accumulation of host
test. Reactivation of the latent M. tuberculosis infection cell–derived cholesterol in the plasma membrane at the
often occurs in apparently healthy people, and very fre- point of bacterial entry (Gatfield and Pieters, 2000).
quently in people who are immunosuppressed as a re- These experiments and others yield a relatively detailed
sult of diseases such as AIDS. view of the biochemical events that accompany myco-
Reactivation of Tuberculosis most commonly occurs bacterial vacuolar trafficking within the macrophage.
in the lung, but can involve any organ. The disease is a However, the specific bacterial proteins or cell envelope
chronic wasting illness characterized by fever, weight components that interact with the host cell to perturb
loss, and in the case of pulmonary reactivation, cough. these processes are completely unknown. In addition,
The cough of Tuberculosis is both a symptom of chronic we do not understand the relationship between altered
pulmonary inflammation and the mechanism by which intracellular trafficking of M. tuberculosis in macro-
the organism disseminates to new hosts. Many of the
phages and development of the granulomatous pathol-
symptoms of Tuberculosis, including the tissue destruc-
ogy characteristic of M. tuberculosis infection. There-
tion that eventually liquefies infected portions of the
fore, a major goal of future studies will be to understandlung, is mediated by the host immune response against
the relationship between specific M. tuberculosis prod-Mycobacterium tuberculosis rather than a direct toxicity
ucts, intracellular survival within macrophages, and theof the bacterium itself. Understanding the interplay be-
interrelationships between these altered macrophagetween the host immune response and bacterial patho-
responses and the complex multicellular pathology ofgenic strategies remains a major goal of investigation
the infection that mediates tissue destruction and clini-into M. tuberculosis pathogenesis.
cal symptoms.Based on this understanding of the clinical behavior
of M. tuberculosis, the organism must have evolved to
Animal Models of M. tuberculosis Replicationsuccessfully execute several distinct but sequential
and Persistencepathogenic strategies. First, the organism must suc-
As detailed above, the natural history of M. tuberculosiscessfully replicate within host macrophages, a property
infection in humans has distinct phases of replication,shared with other intracellular bacterial pathogens but
dissemination, establishment and maintenance of la-apparently achieved through unique mechanisms that
tency, and reactivation. There is no adequate animalare discussed below. Second, the organism must either
model for this complex natural history. The mouse isresist the host immune response or modify this immune
frequently used for experimental M. tuberculosis infec-response to allow the host to control bacterial replica-
tion due to the ease of housing in biosafety level 3tion without sterilization. Third, M. tuberculosis must be
facilities, well characterized inbred strains includingable to persist within its host in a relatively inactive
knockout mice, and the abundance of commerciallystate, retaining the potential for reactivation. All of these
available reagents. Other animal models, including guineastages of infection represent distinct environments to
which the organism must respond through the coordi- pigs and rabbits, have contributed greatly to our under-
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et al., 1985b; Jacobs et al., 1986). Genetic tools for the
mycobacteria have been difficult to develop because
of the inefficiency of transformation and homologous
recombination. Thankfully, many of these obstacles
have been surmounted such that transformation with
episomal and integrating plasmids (Jacobs et al., 1987;
Snapper et al., 1988) and efficient transposon mutagen-
esis are now possible (McAdam et al., 1995; Bardarov
et al., 1997; Pelicic et al., 1997). The use of conditionally
replicating plasmids and counterselectable markers
have greatly facilitated gene replacements through al-
lelic exchange (Pelicic et al., 1996; Pavelka and Jacobs,
1999). In addition, the recent use of conditionally repli-
cating mycobacteriophages (Bardarov et al., 1997) to
mediate allelic exchange (Glickman et al., 2000, 2001)
Figure 1. Mouse Model of M. tuberculosis Growth and Persistence shows tremendous promise. The combination of these
Illustrating Wild-type and Mutant Phenotypes
efficient mutagenesis strategies of the M. tuberculosis
Wild-type M. tuberculosis replicates for 2–3 weeks in the lungs genomic sequence coupled with rigorous complemen-
of mice until the onset of specific immunity. After this point, the
tation of mutant phenotypes provides an unparalleledorganisms persist at a constant titer. Three types of theoretical
opportunity to define the molecular bases for uniquemutant phenotypes could be anticipated. Growth in vivo (giv) mu-
tants are defective for replication in the initial stage of infection. properties of the mycobacteria.
Severe giv (sgiv) mutants do not replicate at all in vivo. Finally,
persistence mutants (per) replicate normally but decline in titer after Distinctive Features of the M. tuberculosis
the onset of host immunity. Specific examples of each mutant class
Genome Sequencehave recently been isolated and are discussed in the text.
The complete nucleotide sequence of the circular chro-
mosome M. tuberculosis strain H37Rv was completed in
1998 (Cole et al., 1998) and has dramatically acceleratedstanding of M. tuberculosis infection in animals, includ-
ing vaccine efficacy (Dannenberg, 1994; McMurray, investigation into M. tuberculosis pathogenesis. Several
novel features of the M. tuberculosis genome are evident1994). Unfortunately, the immune systems of these ani-
mals, while capable of controlling M. tuberculosis repli- and deserve mention due to their possible relationship
to pathogenesis. This topic has been reviewed recentlycation, cannot reduce the viability of M. tuberculosis
such that a latent state ensues. The time course of the (Brosch et al., 2000).
Approximately 9% of the M. tuberculosis genomemurine M. tuberculosis lung infection is shown in Fig-
ure 1. After replicating logarithmically for two or three consists of two related families of genes that have been
named the PE and PPE families (Cole et al., 1998). Theseweeks, the organisms are controlled by the onset of
specific immunity. A prolonged stage of persistence names derive from the presence of conserved proline-
glutamate (PE) or proline-proline-glutamate (PPE) resi-then ensues during which a constant titer is maintained
and the animal is relatively free of symptomatic disease. dues near the N terminus of the predicted proteins of
the family. These predicted proteins share a conservedDuring this persistence phase, there is minimal bacterial
replication (Rees and Hart, 1961). Although the large N-terminal domain of z110 amino acids (PE) or 180
amino acids (PPE) with divergent C-terminal sequencesnumbers of bacilli in this phase of the murine infection
clearly do not mimic the latent state in the human host, (Brosch et al., 2000). A subfamily of the PE family has
been designated the PGRS proteins based on C-termi-the constant titer does represent an equilibrium between
the persisting pathogen and the host immune response. nal extensions rich in a repetitive glycine/alanine (GA)
motif. A recent search for Mycobacterium marinum pro-It is likely that a distinct set of M. tuberculosis gene
products mediates this persistence in mice; gene prod- moters that were active within granulomas of host frogs
identified two members of the PGRS family (Ramakrish-ucts that may be important for paucibacillary latency of
the human host. Consequently, when evaluating mu- nan et al., 2000). Deletion mutants of these genes in M.
marinum were impaired for replication within macro-tants of M. tuberculosis that may be defective for in vivo
growth, several theoretical phenotypes are possible. phages and reached lower titers in frog tissues at 8
weeks compared to wild-type organisms. These resultsMutants could fail to grow at all in vivo (sgiv mutants), or
replicate substantially less than wild type (giv mutants). confirm the suspected importance of this gene family
based on genomics. In addition, one member of the PPEOther mutants might replicate normally in vivo, but then
fail to persist (per mutants) (Figure 1). As will be detailed family of proteins is necessary for in vivo growth of
M. tuberculosis (Camacho et al., 1999). It is presentlybelow, both of these types of mutants have now been
identified, and thus far these giv and per phenotypes unclear whether the common sequence motifs of these
gene families reflect related functions of the proteins orare genetically mutually exclusive.
represent a mechanism of antigenic variation, as has
been suggested (Cole et al., 1998).Systems for Generating Mutants
and Transferring Genotypes A large portion of the coding capacity of the M. tuber-
culosis genome is putatively involved with lipid biosyn-Mycobacteria began to enter the genetic world with
the successful cloning and expression of genes of M. thesis or lipid degradation. One of the most prominent
classes of genes represented in the genome are homo-tuberculosis (Young et al., 1985a) and M. leprae (Young
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logs of the fatty acid b oxidation system. E. coli is able lease from macrophages (Chatterjee et al., 1992), and
scavenge oxygen free radicals (Chan et al., 1991). TDM,to metabolize fatty acids as a sole carbon source
a mycolic acid–containing glycolipid, can produce gran-through the action of the Fad system, comprised of
ulomatous inflammation and thymic atrophy when in-FadA, FadB, FadD, and FadE (Clark and Cronan, 1996).
jected into mice (Ozeki et al., 1997) in addition to affect-This system catalyzes the b oxidation of fatty acids to
ing membrane fusion in model systems (Spargo et al.,produce acetyl-CoA, which then enters the Krebs cycle
1991) and toxicity for mitochondria. The phthiocerol di-in the presence of an active glyoxylate bypass. The first
mycocerosate family of complex lipids in the cell enve-step in the b oxidation cycle is coupling of the fatty acid
lopes of pathogenic mycobacteria can suppress lym-to coenzyme A, catalyzed by FadD (acyl-CoA synthe-
phocyte responses (Prasad et al., 1987; Vachula et al.,tase). This protein is encoded by a single copy gene in
1989) and were recently shown to bind to peripheralthe E. coli chromosome and is able to process fatty
nerve laminin and facilitate Schwann cell invasion byacids of heterogeneous carbon lengths (Kameda and
Mycobacterium leprae (Ng et al., 2000). Yet despite suchNunn, 1981). The M. tuberculosis genome contains 36
an elaborate array of bioactive chemical entities in theFadD and 36 FadE homologs (Cole et al., 1998). Many
cell envelope of pathogenic mycobacteria, detailed un-of these FadD genes appear to be transcribed in operons
derstanding of the role of each of these molecules inwith polyketide synthases, suggesting that they may
M. tuberculosis pathogenesis has been limited due tobe involved in lipid synthesis, rather than degradation.
the lack of defined mutants defective in the synthesis ofIndeed, FadD28 is necessary for synthesis of phthio-
individual molecules. With the advent of efficient geneticcerol dimycocerosate both in M. tuberculosis (Cox et
systems for slow growing mycobacteria, rigorous ge-al., 1999) and BCG (Fitzmaurice and Kolattukudy, 1998).
netic analysis of the role of the cell envelope in patho-Nevertheless, the presence of multiple homologs of the
genesis has recently begun.canonical b oxidation machinery suggests that M. tuber-
Using signature-tagged mutagenesis to screen forculosis assimilates lipids as important carbon sources.
mycobacterial genes important for in vivo growth, twoSupporting this notion are studies demonstrating that
groups identified a cluster of M. tuberculosis genes nec-M. tuberculosis harvested from mouse tissues preferen-
essary for replication of M. tuberculosis in mice (Cama-tially metabolizes fatty acids as carbon sources (Segal
cho et al., 1999; Cox et al., 1999). One of these groupsand Bloch, 1956; Wheeler and Ratledge, 1988). Thus,
also demonstrated that inactivation of two genes in thisthe abundance of b oxidation machinery may indicate
region abolished synthesis of phthiocerol dimycocero-that M. tuberculosis is equipped to utilize a diverse array
sate (PDIM), a complex lipid noncovalently attachedof lipids as carbon sources during infection and that the
to the mycobacterial cell envelope (Cox et al., 1999).structural diversity of the lipids available in vivo necessi-
In addition, a third mutant with the same in vivo pheno-tates a diversity of FadD enzymes. The sources of these
type contained a transposon insertion in a gene of un-lipids are not completely clear, but could originate in
known function with homology to membrane transport-host tissues (Barclay and Wheeler, 1989) or from the
ers (mmpL7). This mutant synthesized PDIM, but failed toabundant lipids in the cell envelope that could be catab-
localize the lipid within the cell wall such that, in contrastolized under conditions of nutrient limitation.
to wild type, the lipid was not present in the culture
supernatant. In addition, all three mutants displayed rep-
M. tuberculosis Pathogenicity: Central Role
lication defects only in the lungs, showing that synthesis
of Lipid Effectors and Lipid Metabolism and proper transport of PDIM is necessary for organ-
The cell envelope of M. tuberculosis has been studied specific replication of M. tuberculosis.
intensely for many decades due to its distinctive archi- Further evidence for the role of an individual lipid
tecture and composition (Brennan and Nikaido, 1995; molecule in M. tuberculosis replication in vivo came with
Daffe and Draper, 1998). The M. tuberculosis cell enve- the disruption of the mmaA4 gene (Dubnau et al., 2000).
lope differs substantially from the canonical cell wall MmaA4 is one member of large family of SAM-depen-
structures of both gram-negative and gram-positive dent methyl transferases that modify the mycolic acids
bacteria (Figure 2). In addition to the cell membrane and of the M. tuberculosis cell wall by introducing cyclopro-
peptidoglycan layers found in other bacteria, the cell pane rings and methyl branches (Barry et al., 1998). This
envelope contains a large hydrophobic layer of mycolic mutant did not synthesize oxygenated mycolic acids,
acids, long chain branched b hydroxyl fatty acids that and therefore lacked two of the three major classes of
exist either covalently attached to the cell wall or nonco- mycolic acids present in the cell envelope. This mutant
valently attached in the form of Trehalose dimycolate was impaired for initial replication in vivo, but then per-
(TDM). In addition to these mycolic acids, the cell enve- sisted normally at this lower titer (Dubnau et al., 2000),
lope contains a wide array of distinctive lipids and glyco- establishing a role for a specific subclass of mycolic
lipids that associate noncovalently with the envelope. acids in mycobacterial replication in vivo.
This vast array of lipids and glycolipids confers extreme Other classes of M. tuberculosis genes important for
hydrophobicity to the outer surface of the organism. growth in vivo do not obviously relate to the cell en-
Many of these compounds have potent biologic activ- velope. Reasoning that secreted proteins would be
ity when tested on eukaryotic cells in in vitro systems, important for M. tuberculosis virulence, Berthet and
raising the possibility that they may be important for colleagues identified erp, a repetitive protein that is es-
pathogenesis. Lipoarabinomannan, a major cell wall as- sential for normal replication of M. tuberculosis in mac-
sociated glycolipid, has been extensively examined in rophages and mice (Berthet et al., 1998). Mycobacteria
vitro and can inhibit gamma interferon activation of mac- encounter a chemically hostile environment inside the
macrophage that includes both reactive oxygen androphages (Sibley et al., 1988, 1990), induce TNF a re-
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Figure 2. Schematic Diagram of the Cell En-
velope of M. tuberculosis
Similar to classical bacterial cell walls, the
cell envelope of M. tuberculosis contains a
cell membrane (CM) and a peptidoglycan
layer (PG). In contrast to other bacteria, M.
tuberculosis has a thick hydrophobic layer of
mycolic acids esterified to the cell wall,
named the mycolyl arabinogalactan (MAG). A
variety of unique lipids and glycolipids are
noncovalently associated with the cell enve-
lope and are depicted schematically, includ-
ing Trehalose dimycolate, phthiocerol dimy-
cocerate, and Lipoarabinomannan, among
others. Many of these molecules are potent
immunomodulators, suggesting a role in viru-
lence that is discussed in the text. The depic-
tions of these compounds is schematic and
not intended to convey precise localization,
which in many cases is not definitively known.
reactive nitrogen intermediates (Chan et al., 1992). M. over the first 2 weeks of the infection, but then declined
in titer after the onset of specific immunity. This studytuberculosis produces a catalase-peroxidase (katG) that
is often inactivated in isoniazid-resistant strains. These confirmed the importance of icl not only for in vivo sur-
vival of M. tuberculosis, but specifically for persistence.strains are less virulent for mice than wild-type strains,
and this loss of virulence is corrected by a functional These results imply that M. tuberculosis must utilize
acetyl-CoA as a carbon source for multibacillary persis-copy of katG (Li et al., 1998), establishing the importance
of this gene for in vivo survival. tence in mice, but not for active replication. This metabolic
phenotype was dependent upon host gamma-interferon,
suggesting a responsive relationship between bacterialPersistence Genes of M. tuberculosis
Identification of the molecules that M. tuberculosis uses in vivo metabolism and the host immune system (McKin-
ney et al., 2000). As humans do not have a functionalto persist within its host is of great interest. Understand-
ing the mechanisms by which this organism can persist glyoxylate shunt, icl represents an attractive drug target.
Another class of persistence genes was recently dis-might allow the design of antibiotics that would specifi-
cally target persisting or latent bacilli, allowing shorten- covered through the examination of mycobacterial col-
ony morphology (Glickman et al., 2000). Screening foring of chemotherapy. In addition, in the design of a
rationally attenuated M. tuberculosis vaccine strain, mu- mutants of BCG that could not form serpentine cords,
a colony morphology associated with virulence, the au-tations that affect persistence would prevent the vac-
cine strain from establishing latency and reactivating, thors identified a novel methyl transferase, pcaA, puta-
tively involved in the modification of mycolic acids inan important safety consideration. A mutant that fails to
grow or persist may also invoke a qualitatively different the cell envelope. Deletion of this gene in M. tuberculosis
by specialized transduction revealed that pcaA synthe-immune response and therefore be a more effective
immunogen when used as a vaccine. Two classes of sizes a single cyclopropane residue on the major my-
colic acid of the cell envelope. These pcaA mutants alsopersistence genes have recently been identified.
The glyoxylate shunt allows bacteria and plants to replicated normally, but were defective for persistence
in mice such that bacterial titers dropped during chronicgrow on acetate or fatty acids as sole carbon sources.
The glyoxylate shunt enzyme isocitrate lyase (Icl) is infection and the mice did not succumb. In addition, the
inflammatory infiltrate in the lungs of mice chronicallyupregulated in M. tuberculosis exposed to anaerobic
conditions (Wayne and Lin, 1982), stationary phase, and infected with the pcaA mutant was predominantly lym-
phocytic, in contrast to the granulomatous inflammationgrowth within macrophages (Graham and Clark-Curtiss,
1999; Honer Zu Bentrup et al., 1999). In addition, as of wild-type infected mice. These results provided fur-
ther evidence for the importance of specific moleculesmentioned above, previous work had shown that M.
tuberculosis harvested from mouse tissues metabolizes of the cell envelope in pathogenesis and implicated the
fine structure of mycolic acid subclasses in the interac-fatty acids as a carbon source in preference to glucose,
raising the possibility that M. tuberculosis is lipolytic in tion of M. tuberculosis with the host immune system
during long-term persistence in vivo. Both prior datavivo and therefore would require the glyoxylate shunt
for survival. Genetic proof that the glyoxylate shunt is (reviewed in Barry et al., 1998) and the M. tuberculosis
genome sequence identified a large family of cyclopro-required for M. tuberculosis survival in vivo was recently
reported (McKinney et al., 2000). An isocitrate lyase mu- pane synthetases highly homologous to pcaA, each of
which appears to synthesize a unique cyclopropane res-tant of M. tuberculosis replicated identically to wild type
Cell
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idue in the cell wall (Glickman et al., 2001). The role of
each member of this gene family in pathogenesis re-
mains to be defined.
Despite the relative paucity of defined mutants of M.
tuberculosis altered for in vivo growth, certain themes
have already emerged. Lipid synthesis for the construc-
tion of the cell envelope, and lipid degradation by the
bacterium for survival within the host, have emerged
as centrally important. Before the isolation of specific
mutants in cell envelope biosynthesis, the mycobacte-
rial cell envelope appeared to be a redundant waxy
coating that conferred extreme hydrophobicity to the
organism through the combined presence of structurally
diverse molecules. Now, one can view the mycobacterial
cell envelope as an array of distinct lipid effector mole-
cules, each with its own role in modulating the inter-
action of M. tuberculosis with its host. This novel
pathogenic strategy is reflected by the distinct in vivo
phenotypes of the mutants in genes required for PDIM
synthesis, mma4, and pcaA. If these lipids were simply
redundant members of an inert waxy coat, then the
phenotypes of these mutants would be similar, yet they
are distinct. In addition, the finding that PDIM is trans-
ported by mmpL7 suggests that the large family of
mmpL proteins in the genome of M. tuberculosis may
also be involved in lipid export. While further work is
necessary to know whether all of the mmpL family mem-
bers function to transport lipids to their correct locations
within the cell envelope or to the extracellular environ-
ment, clearly mmpL7 is required for PDIM to appear in
the media of in vitro grown organisms. Supporting this
concept of exported lipid effectors, recent data demon-
strates that mycobacterial lipids can be found within
Figure 3. The Export of Lipid Effectors as a Novel Pathogenic Strat-
the cytoplasm of host macrophages, free of the intact egy of M. tuberculosis
bacterium (Beatty et al., 2000). It is tempting to speculate
(A) Schematic representation of a gram-negative pathogen ex-
that the MmpL family of putative lipid transporters is porting protein effectors into the host cell through a type III secretion
involved in the export of lipid effector molecules into system.
(B) M. tuberculosis within the phagocytic vacuole exports lipid ef-the host cell. This model is illustrated in Figure 3, where
fectors into the host cell membranes or cytoplasm. Lipids and glyco-it is compared and contrasted to an analogous system
lipids from the organism may modify the vacuolar membrane orfrom gram-negative pathogens. Gram-negative bacte-
interact with specfic ligands in the host cell cytoplasm. This lipidrial pathogens deliver protein effector molecules to the
export is probably accomplished in part by the family of mmpL
surface or the cytoplasm of the host cell through a pro- proteins, one of which transports PDIM, an M. tuberculosis lipid
tein export machinery known as type III protein secre- essential for virulence.
tion. Depending on the pathogen studied, these protein
effectors have diverse effects on host cell function, in-
cluding inhibition of phagocytosis, perturbation of signal Host Factors in M. tuberculosis Infection
transduction, cytoskeletal rearrangement (reviewed in While this review has focused primarily on recently delin-
Finlay and Cossart, 1997), and insertion of a bacterial eated microbial strategies of pathogenesis, many of the
receptor in the host cell membrane (Kenny et al., 1997). clinical symptoms and tissue destruction of M. tubercu-
While there are no pathogenicity islands or type III secre- losis infection are mediated by the host inflammatory
tion systems evident in the genome of M. tuberculosis, response. The cornerstones of antimycobacterial im-
the mmpL system probably functions as an exporter munity have been examined in experimental animals
of lipids into host cell membranes or to the host cell through use of knockout mice. Interferon Gamma is criti-
cytoplasm as pathogenesis effectors. Definition of the cal for the control of M. tuberculosis infection in mice
range of lipids exported, their subcellular localization (Cooper et al., 1993; Flynn et al., 1993), as are Interleukin
within the host cell, the specific host cellular targets 12 (Cooper et al., 1997), and CD4-positive T cells (Scanga
affected by exported lipids, and the consequences of et al., 2000). Beyond these pillars of antimicrobial immu-
this interaction all await further work. Nevertheless, the nity, defined polymorphic determinants of susceptibility
incredible chemical diversity of the lipids and glycolipids to mycobacterial infection in mice are limited to Nramp1
in the mycobacterial cell envelope is likely to mediate for BCG and the recently identified sst1 locus for M.
specific interactions with host ligands or membranes tuberculosis (Kramnik et al., 2000). In humans, polymor-
rather than existing solely to determine the hydropho- phisms in the Interferon Gamma pathway clearly predis-
pose to severe mycobacterial infections (Altare et al.,bicity and rigidity of the bacterial cell wall.
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tionally replicating mycobacteriophages: a system for transposon1998; Jouanguy et al., 1999). However, the host genetic
delivery to Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USAfactors that affect more subtle aspects of M. tuberculo-
94, 10961–10966.sis infection in humans remain obscure. For example,
Barksdale, L., and Kim, K.S. (1977). Mycobacterium. Bacteriol. Rev.why do the vast majority of people infected with M.
41, 217–372.
tuberculosis contain the infection while a minority de-
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